Previous 10 | Next 10 |
Co-Diagnostics (NASDAQ:CODX) announced its joint venture in India, CoSara Diagnostics, received clearance from the regulatory authorities to manufacture and sell SARAQ Hepatitis B (HBV) Viral Load Kit there as an in vitro diagnostic ("IVD"). The real-time PCR test for HBV is based on Co-Diagn...
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test PR Newswire SALT LAKE CITY , Feb. 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a...
Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27 PR Newswire SALT LAKE CITY , Jan. 21, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented...
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test PR Newswire SALT LAKE CITY , Jan. 13, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with...
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13 PR Newswire SALT LAKE CITY , Jan. 10, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company w...
Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform PR Newswire SALT LAKE CITY , Dec. 31, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"),...
The last week of the year is turning out to be a rough one for many COVID-19 related stocks. Shares of Co-Diagnostics (NASDAQ: CODX) were sinking 12.4% for the week as of the market close on Thursday. Ocugen (NASDAQ: OCGN) was down 5.5% after plunging as much as 19.2% earlie...
Co-Diagnostics (NASDAQ: CODX) saw its shares rise 15.8% on Monday. The molecular diagnostics company, which closed at $9.41 on Thursday, opened at $9.50 on Monday and rose to $10.90 shortly after noon. The company is up more than 9.9% for the year. The stock is still closer to its 5...
Co-Diagnostics (CODX +12.1%) shares are trading at the highest level since mid-September after the company announced a transaction under which Advanced Conceptions and Idaho Molecular will become two of its subsidiaries. On Dec 21, the company has struck two separate agreements and plans...
Co-Diagnostics (NASDAQ:CODX) enters into definitive agreements with Idaho Molecular and Advanced Conceptions, pursuant to which each of them will become wholly-owned subsidiaries of CODX. The deals will provide CODX with all existing and future assets and intellectual property related to the ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...